Prescription drug · ANDA
Glipizide NDC 71610-680
Glipizide 5 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-680-45 | 71610068045 | 45 TABLET in 1 BOTTLE (71610-680-45)Marketed from Dec 9, 2022 | |
| 71610-680-60 | 71610068060 | 90 TABLET in 1 BOTTLE (71610-680-60)Marketed from Dec 9, 2022 | |
| 71610-680-73 | 71610068073 | 135 TABLET in 1 BOTTLE (71610-680-73)Marketed from Apr 14, 2023 | |
| 71610-680-80 | 71610068080 | 180 TABLET in 1 BOTTLE (71610-680-80)Marketed from Dec 9, 2022 | |
| 71610-680-92 | 71610068092 | 270 TABLET in 1 BOTTLE (71610-680-92)Marketed from Dec 9, 2022 | |
| 71610-680-98 | 71610068098 | 540 TABLET in 1 BOTTLE (71610-680-98)Marketed from Mar 17, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glipizide
- Generic name (nonproprietary)
- glipizide
- Active ingredients
- Glipizide — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074497
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 71610-680_737c6102-3cac-4ef5-812b-13e0298c7210SPL ID 737c6102-3cac-4ef5-812b-13e0298c7210SPL set ID 64c2a82f-014c-47d7-b303-23531e6bb723RxCUI 310488, 310490UNII X7WDT95N5C
- Pharmacologic class
- Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610068045followed by a unit qualifier and the quantityPackage 71610-0680-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Glipizide Tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074497
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glipizide | Glipizide 5 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3548 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0437 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-620 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-621 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2215 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-7405 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-7404 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-315 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-316 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-9614 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-668 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2520 |